中国医药导报
中國醫藥導報
중국의약도보
CHINA MEDICAL HERALD
2014年
18期
4-8
,共5页
蒋忠科%张洋%郭连宏%姜蓉%孙承航
蔣忠科%張洋%郭連宏%薑蓉%孫承航
장충과%장양%곽련굉%강용%손승항
血管内皮细胞生长因子受体-2胞内酪氨酸激酶%链霉菌%二酮哌嗪%拮抗剂
血管內皮細胞生長因子受體-2胞內酪氨痠激酶%鏈黴菌%二酮哌嗪%拮抗劑
혈관내피세포생장인자수체-2포내락안산격매%련매균%이동고진%길항제
VEGFR2-CD%Streptomyces%Diketopiperazines%Antagonist
目的:分离鉴定链霉菌I06A-03304发酵液中具血管内皮细胞生长因子受体-2胞内酪氨酸激酶(VEGFR2-CD)抑制活性的次生代谢产物。方法采用大孔吸附树脂、羟丙基葡聚糖凝胶(Sephadex LH-20)、C-18反相色谱(ODS)、高压液相色谱(HPLC)等分离手段对次生代谢产物进行分离纯化;通过二级质谱(ESI+-MS2)、紫外光谱(UV)、红外光谱(IR)、核磁共振波谱(NMR)对其结构进行鉴定,以酶联免疫吸附试验(ELISA)法检测其次生代谢产物对VEGFR2-CD的抑制活性。结果分离得到两个二酮哌嗪类化合物院3304A和3304C;化合物3304A的化学结构与环(脯氨酸-亮氨酸)一致,化合物3304C的化学结构与环(脯氨酸-苯丙氨酸)一致,均对VEGFR2-CD表现出一定的抑制活性。结论化合物3304A和3304C是具有VEGFR2-CD抑制活性的二酮哌嗪类次生代谢产物,并为本研究首次报道。
目的:分離鑒定鏈黴菌I06A-03304髮酵液中具血管內皮細胞生長因子受體-2胞內酪氨痠激酶(VEGFR2-CD)抑製活性的次生代謝產物。方法採用大孔吸附樹脂、羥丙基葡聚糖凝膠(Sephadex LH-20)、C-18反相色譜(ODS)、高壓液相色譜(HPLC)等分離手段對次生代謝產物進行分離純化;通過二級質譜(ESI+-MS2)、紫外光譜(UV)、紅外光譜(IR)、覈磁共振波譜(NMR)對其結構進行鑒定,以酶聯免疫吸附試驗(ELISA)法檢測其次生代謝產物對VEGFR2-CD的抑製活性。結果分離得到兩箇二酮哌嗪類化閤物院3304A和3304C;化閤物3304A的化學結構與環(脯氨痠-亮氨痠)一緻,化閤物3304C的化學結構與環(脯氨痠-苯丙氨痠)一緻,均對VEGFR2-CD錶現齣一定的抑製活性。結論化閤物3304A和3304C是具有VEGFR2-CD抑製活性的二酮哌嗪類次生代謝產物,併為本研究首次報道。
목적:분리감정련매균I06A-03304발효액중구혈관내피세포생장인자수체-2포내락안산격매(VEGFR2-CD)억제활성적차생대사산물。방법채용대공흡부수지、간병기포취당응효(Sephadex LH-20)、C-18반상색보(ODS)、고압액상색보(HPLC)등분리수단대차생대사산물진행분리순화;통과이급질보(ESI+-MS2)、자외광보(UV)、홍외광보(IR)、핵자공진파보(NMR)대기결구진행감정,이매련면역흡부시험(ELISA)법검측기차생대사산물대VEGFR2-CD적억제활성。결과분리득도량개이동고진류화합물원3304A화3304C;화합물3304A적화학결구여배(포안산-량안산)일치,화합물3304C적화학결구여배(포안산-분병안산)일치,균대VEGFR2-CD표현출일정적억제활성。결론화합물3304A화3304C시구유VEGFR2-CD억제활성적이동고진류차생대사산물,병위본연구수차보도。
Objective To discover antagonists of VEGFR2-CD from the fermentation broth produced by streptomyces strain I06A-03304. Methods Under guidance of ELISA assay against VEGFR2-CD, compounds 3304A and 3304C were isolated and purified by HP-20 absorption resin, Sephadex LH-20 gel, ODS reversed-phase chromatography and semi-preparative HPLC. The structures of compounds 3304A and 3304C were identified by combination of analysis of UV, IR, ESI+-MS2 and NMR. Results Compounds 3304A and 3304C were purified and structurally identified as dike-topiperazines, and were the same with cyclo-(Pro-Leu) and cyclo-(Pro-Phe) respectively. Compounds 3304A and 3304C showed weak antagonistic activity against VEGFR2-CD by ELISA assay. Conclusion For the first time, it is re-ported diketopiperazine compounds 3304A and 3304 C have antagonistic activity against VEGFR2-CD.